3 Ways to Invest in AI & Machine Learning
Ryan Allway June 16th, 2021 Psychedelics, Top Story Artificial intelligence has revolutionized computer science over the past decade. In fact, in a new paper submitted to the peer-reviewed Artificial Intelligence journal, scientists at the UK-based AI lab DeepMind argue that generalized intelligence will emerge from the reinforcement learning and... Read more
Dr. Jeffrey Kamlet Internationally Recognized Expert on Cardiac Safety in Ibogaine Treatment Joins Ehave as Chief Medical Officer
Ryan Allway June 15th, 2021 Psychedelics New Position Created to Deepen Clinical Expertise and Advance Pipeline Clinical Programs MIAMI, June 15, 2021 (GLOBE NEWSWIRE) — Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today the appointment of... Read more
Ketamine One Signs Definitive Agreement to Acquire Integrated Rehab and Performance Ltd.
Ryan Allway June 3rd, 2021 Psychedelics VANCOUVER, British Columbia, June 03, 2021 (GLOBE NEWSWIRE) — KetamineOne Capital Limited (formerly, Myconic Capital Corp.) (“Ketamine One” or the “Company”) (NEO: MEDI), a company focused on consolidating medical clinics and becoming a North American leader in mental health treatments, is pleased to... Read more
Optimi Health Announces DTC Eligibility & Up-List to OTCQB
Ryan Allway June 3rd, 2021 Psychedelics VANCOUVER, BC (GLOBE NEWSWIRE – June 3, 2021) — Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated functional mushroom brand focused on the health and wellness sector, is pleased to announce that its US-based OTC... Read more
Silo Wellness Partners with Mushe Inc. to Establish First Legal Brick & Mortar Psychedelic and Functional Mushroom Shop in the Western Hemisphere
Ryan Allway June 2nd, 2021 Psychedelics MONTEGO BAY, Jamaica, June 02, 2021 (GLOBE NEWSWIRE) — Silo Wellness Inc. (“Silo Wellness” or “the Company”) (CSE: SILO) (FRA: 3K70), a leading global psychedelics company, today announced it has signed a binding letter of intent with Canadian-based mushroom company Mushe Inc. (“Mushe”) to... Read more
BetterLife Pharma Appoints Henri Sant-Cassia of The Conscious Fund to its Board of Directors
Ryan Allway June 2nd, 2021 Psychedelics VANCOUVER, British Columbia, June 02, 2021 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB : BETRF / FRA: NPAU), an emerging biotech company, is pleased to announce that it has appointed Mr. Henri Sant-Cassia, co-founder of The... Read more
Field Trip Health Ltd. Receives Conditional Approval to Up-List to the Toronto Stock Exchange
Ryan Allway May 28th, 2021 Psychedelics TORONTO, May 27, 2021 (GLOBE NEWSWIRE) — Field Trip Health Ltd. (CSE: FTRP; FTRP.WT; OTCQX: FTRPF) (“Field Trip“), a leader in the development and delivery of psychedelic therapies, is pleased to announce that it has received conditional approval to list its common shares... Read more
Psyence Group Corporate Update
Ryan Allway May 27th, 2021 News, Psychedelics TORONTO, May 27, 2021 (GLOBE NEWSWIRE) — Psyence Group Inc. (CSE: PSYG) (“Psyence” or the “Company”) is pleased to provide the following corporate update on its three clear paths to revenue and value creation namely: Psyence Production, Psyence Therapeutics and Psyence Function.... Read more
Algernon Pharmaceuticals Highlights New Animal Study Showing Effectiveness of Psychedelic Drug DMT in Treatment of Stroke
Ryan Allway May 27th, 2021 Uncategorized VANCOUVER, British Columbia, May 27, 2021 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) is pleased to highlight an independent research study from the University of Szeged in Hungary describing the use of N,N-dimethyltryptamine (“DMT”)... Read more
Leading Psychedelic Wellness Platform, Delic, Completes Acquisition of Complex Biotech Discovery Ventures Ltd.
Ryan Allway May 27th, 2021 Psychedelics, Top News New Entity, Delic Labs, to Power Psilocybin and Cannabis R&D, IP and Innovative Product Lines for Mass Markets VANCOUVER, BC, May 27, 2021 /PRNewswire/ – Delic Holdings Inc. (“DELIC” or the “Company“) (CSE: DELC) (OTCQB: DELCF), a psychedelic wellness platform, is pleased to announce that it... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )